<!–
Through Sudinfo with Belga
| Published on 4/12/2021 10:54 AM––
The Swedish-British laboratory AstraZeneca announced Monday that its treatment for diabetes Farxiga was not effective in treating patients with severe Covid-19, according to the first results of clinical trials.
********* ********** ** ******* ******* *** ******* ** ****** *********** *********** **** ********* ** *********** ******** ** ****** **** ** ************
** ******** *** ******** ********** ** ********* ******** *** ** ***** * ***** ******* ** ***** ********** ** ************* **** ************ ********** ************ **** *** ******** ****************** ***** ******** *** ********
************ ****** ************ *************** ** ******* *** *** ******** ************* **** ** ******** ** *** ******** ** *********** *** ************* ** *********** **** *** *********** ****** ********** *********** ***** ***************** ** ******** ** *** ******** ** ***** ** ** *****
*** ********** ******** *** ****** ****** ********** ** *** *********
** ******** ****** ******* ****** **** *********** **** ** ****** ****** ** ******** ******* *** ******** ******** ******************* ********* **** ** ********* ****** *********** ***** *** *** ** ******** *********
******** **** *** ******* *************** ** ******* ****** *** ********** ****** *** ******* ********** ** *** *** ******* ********* *** **** ** ** *** ** ************ *** ** * *********** ***** *********
** ************ ** ****** *** ** ***** ********** ** ***** *************** *** ******** ***** **** * ***** ****** ** *** ** ******* ********* **** *******
*********** ********** *** ******** ** ********** *** ********* ****** ** ******** **** *** ******** ****** **** ** ***** **** ** ******
** ************ ********** * ******** ** ************** ** ** *********** ** ** ****** ******** ** ******* ***** ****** *** ********** ********** ******* ******
— .
